Tag Archive | "Celgene"

BMS and Celgene become pharma partners for evaluating cancer drugs

Tags: , , , ,

Bristol-Myers Squibb and Celgene become a pharma partners for evaluating the efficacy of combination treatment using  OPDIVO and ABRAXANE. Read the full story

NanoString signs a pharma deal with Celegene

Tags: , ,

NanoString Technologies entered into a pharma deal with Celgene to develop a companion diagnostic assay using the nCounter Analysis System to support the clinical validation of REVLIMID for treatment of Diffuse Large B-Cell Lymphoma for $45 million. Read the full story

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The term ‘top pharma’ can relate to the top pharmaceutical companies or the top 10 or 50… Read the full story


Tags: , ,

Celgene is a top pharmaceutical company, incorporated in Delaware and headquartered in Summit, New Jersey Read the full story

Celgene and Nogra enter into a pharma alliance for Crohn’s Disease

Tags: , ,

Celgene entered into a pharma alliance for a global license agreement with Nogra Pharma to develop and commercialize GED-0301, an oral antisense DNA oligonucleotide targeting Smad7 mRNA for the treatment of moderate-to-severe Crohn’s disease and other indications. Read the full story

Forma and Celgene announced a second pharma partnering for unmet medical needs

Tags: , , , ,

FORMA Therapeutics announced a second strategic pharma partnering collaboration and option agreement with Celgene. Read the full story

Celgene and Abide enter into a pharma alliance for inflammation drugs

Tags: , , ,

Abide Therapeutic has entered into a strategic pharma alliance collaboration with Celgene Corporation to discover and develop new drugs in inflammation and immunology. Read the full story

OncoMed pharma partners with Celgene in anti-cancer stem cell therapeutics

Tags: , , , ,

OncoMed Pharmaceuticals and Celgene, big biotech company, pharma partners to jointly develop and commercialize up to six anti-cancer stem cell  product candidates from OncoMed’s biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4) Read the full story

Celgene; Going ‘green’ for transformative technologies

Tags: , , ,

Celgene is a big pharmaceutical company discovering and developing medical treatments indicated for cancer and other inflammatory conditions.

Read the full story

Celgene: M&A activity 2005-2013

Tags: , ,

Celgene has announced over 6 M&A deals since 2005, with the lead deals being the acquisition of decode Abraxis and Pharmion Read the full story

RSS Feed Linked In Twitter

Latest Tweets